Systemic treatment of HER2-positive metastatic breast cancer: A systematic review-Reference-Cited by-同舟云学术

Systemic treatment of HER2-positive metastatic breast cancer: A systematic review

Published:2014-05-06 Issue: Volume:10 Page:1-14
ISSN:1743-7555
Container-title:Asia-Pacific Journal of Clinical Oncology
language:en
Short-container-title:Asia-Pac J Clin Oncol

Author:

Wilcken Nicholas¹,Zdenkowski Nicholas²,White Michelle³,Snyder Ray⁴,Pittman Ken⁵,Mainwaring Paul⁶,Green Michael⁷,Francis Prudence⁸,De Boer Richard⁹,Colosimo Maree⁶,Chua Sue¹⁰,Chirgwin Jacquie¹¹,Beith Jane¹²,Bell Richard¹³

Affiliation:

1. Westmead Hospital; New South Wales Australia

2. Australia & New Zealand Breast Cancer Trials Group; New South Wales Australia

3. Cabrini Hospital; Victoria Australia

4. St Vincent's Hospital; Victoria Australia

5. The Queen Elizabeth Hospital; South Australia Australia

6. Mater Private Breast Cancer Centre; Queensland Australia

7. Western Health; Victoria Australia

8. Peter MacCallum Cancer Centre; Victoria Australia

9. Royal Melbourne Hospital; Victoria Australia

10. Epworth Eastern Hospital; Victoria Australia

11. Box Hill Hospital; Victoria Australia

12. Chris O'Brien Lifehouse; New South Wales Australia

13. Deakin University; Victoria Australia

Publisher

Wiley

Subject

Oncology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajco.12206/fullpdf

Reference85 articles.

1. Cancer Australia Breast cancer in Australia: an overview 2012

2. Roche Products Pty Ltd Pertuzumab Product Information 2013

3. Roche Products Pty Ltd Trastuzumab Product Information 2013

4. Roche Products Pty Ltd Trastuzumab emtansine Product Information 2013

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of cost and infusion-related reactions among intravenous trastuzumab, subcutaneous trastuzumab, and trastuzumab biosimilars at an academic medical center;Journal of Oncology Pharmacy Practice;2024-02-12

2. Single‐cell RNA sequencing to explore cancer‐associated fibroblasts heterogeneity: “Single” vision for “heterogeneous” environment;Cell Proliferation;2023-12-29

3. The Role of the Tumor Microenvironment in Triple-Positive Breast Cancer Progression and Therapeutic Resistance;Cancers;2023-11-20

4. The adverse effects of trastuzumab-containing regimes as a therapy in breast cancer: A piggy-back systematic review and meta-analysis;PLOS ONE;2022-12-01

5. Comparative review of pharmacological therapies in individuals with HER2-positive advanced breast cancer with focus on hormone receptor subgroups;Frontiers in Oncology;2022-08-18